Post-Acute Myocardial Infarction Heart Failure Core Genes and Relevant Signaling Pathways

Ling Lin1, Ling Zicheng2, Gu Shaohua3

  • 1Department of Cardiovascular Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.

Insights

Researchers identified four core genes linked to heart failure following acute myocardial infarction (AMI). These findings may offer new therapeutic targets for post-AMI heart failure and immune dysfunction.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Immunology

Background:

  • Heart failure following myocardial infarction (MI) is a significant clinical concern.
  • Ventricular remodeling after MI presents challenges for current treatments.
  • Understanding the molecular mechanisms of post-MI heart failure is crucial.

Purpose of the Study:

  • To identify key genes associated with heart failure after acute myocardial infarction (AMI).
  • To explore the potential roles of these genes in immune dysfunction and disease regulation.
  • To suggest novel therapeutic targets for post-AMI heart failure.

Main Methods:

  • Differential gene expression analysis.
  • Pathway enrichment analysis.
  • Characteristic gene screening.

Main Results:

  • Identification of four core genes: KLRC2, SNORD105, SNORD45B, and RNU5A-1.
  • Association of these genes with heart failure post-AMI.
  • Exploration of their links to immune dysfunction and disease regulatory networks.

Conclusions:

  • The identified core genes are significant molecular markers for post-AMI heart failure.
  • These genes may play a role in immune dysfunction contributing to heart failure.
  • Clinical relevance in molecular research is vital for developing therapeutic strategies for post-AMI heart failure.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
14
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
22